During the past decade, Ospedale Cà Foncello conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 6 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 5 clinical trials were completed. i.e. 26.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Cà Foncello" #1 sponsor was "Fadoi Foundation, Italy" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 3 trials sponsored, "Anthos Therapeutics, Inc." with 2 trials sponsored and "European Institute of Oncology" with 2 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Cà Foncello" #1 collaborator was "Itreas" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator, "AUSL della Romagna" with 1 trials as a collaborator and "Advanced Clinical, LLC" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Cà Foncello" are "Pulmonary Embolism" (3 trials), "Venous Thromboembolism" (3 trials), "Acute Coronary Syndrome" (2 trials), "Acute Myeloid Leukemia" (2 trials) and "Acute Myocardial Infarction" (2 trials). Many other conditions were trialed in "Ospedale Cà Foncello" in a lesser frequency.

Most popular intervention types in "Ospedale Cà Foncello" are "Drug" (26 trials), "Device" (10 trials), "Other" (7 trials), "Biological" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abelacimab" (2 trials), "Apixaban" (2 trials), "Dalteparin" (2 trials) and "ASA 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Cà Foncello" are 49 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 21 active trials in "Ospedale Cà Foncello". 2 are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Ospedale Cà Foncello, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Cà Foncello, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".